Cancer and Genomic medicine Flashcards
What is metastasis?
Metastasis refers to the spread of cancer cells from the primary site to distant tissues and organs.
What are carcinomas?
Carcinomas are cancers that arise from epithelial cells and form solid tumors
What are sarcomas?
Sarcomas arise from connective or muscular tissue.
What are leukemias, lymphomas, and myelomas?
These cancers affect blood cells.
What is sporadic cancer?
Sporadic cancer is caused by environmental exposure or unknown factors, without a clear hereditary pattern.
What is inherited cancer?
Inherited cancer follows a clear genetic inheritance pattern, often affecting younger individuals.
What are proto-oncogenes?
Proto-oncogenes are genes that promote cell growth and division; mutations can convert them into oncogenes, leading to uncontrolled cell proliferation.
What are tumor suppressor genes?
Tumor suppressor genes limit cell growth and division; mutations can lead to cancer development. Examples: BRCA1, BRCA2, p53.
What are DNA repair genes?
DNA repair genes correct errors during DNA replication; mutations make cells more prone to cancer.
What is the role of RB in cancer?
RB regulates the G1/S cell cycle transition. Loss of function mutations in RB are common in many cancers, including retinoblastoma.
What is TP53’s role in cancer?
TP53 regulates cell cycle, DNA repair, and apoptosis. Mutations in TP53 are present in over 50% of human cancers
What is the role of hypermethylation in cancer?
Hypermethylation can silence tumor suppressor genes, contributing to cancer progression.
What are miRNAs in cancer?
Certain miRNAs, like Oncom-miRs, can promote cancer progression by regulating gene expression.
What is the significance of BRCA1 and BRCA2 mutations in breast cancer?
These mutations significantly increase the risk of developing breast cancer.
What are the molecular subtypes of breast cancer?
Luminal A: Better prognosis, sensitive to endocrine therapy.
Luminal B: Resistant to endocrine therapy, sensitive to chemotherapy.
HER2+: Responds to anti-HER2 therapy.
Basal-like: Lacks expression of ER, PR, and HER2 receptors